SG Americas Securities’s Atara Biotherapeutics ATRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,189
Closed -$21K 2845
2024
Q1
$21K Sell
1,189
-808
-40% -$14.3K ﹤0.01% 2858
2023
Q4
$26K Buy
1,997
+447
+29% +$10.4K ﹤0.01% 2990
2023
Q3
$57K Buy
+1,550
New +$69K ﹤0.01% 2908
2023
Q2
Sell
-1,388
Closed -$101K 2297
2023
Q1
$101K Buy
1,388
+311
+29% +$30.2K ﹤0.01% 2909
2022
Q4
$88K Sell
1,077
-195
-15% -$20.3K ﹤0.01% 2752
2022
Q3
$120K Sell
1,272
-1,416
-53% -$159K ﹤0.01% 2713
2022
Q2
$524K Sell
2,688
-5,567
-67% -$909K 0.01% 1917
2022
Q1
$1.92M Sell
8,255
-479
-5% -$153K 0.01% 949
2021
Q4
$3.44M Sell
8,734
-1,276
-13% -$537K 0.02% 696
2021
Q3
$4.48M Buy
10,010
+2,061
+26% +$738K 0.02% 613
2021
Q2
$3.09M Buy
7,949
+4,823
+154% +$1.72M 0.01% 853
2021
Q1
$1.12M Buy
3,126
+2,559
+451% +$1.13M 0.01% 1455
2020
Q4
$278K Sell
567
-551
-49% -$254K ﹤0.01% 2423
2020
Q3
$362K Buy
+1,118
New +$381K ﹤0.01% 1827
2020
Q2
Sell
-433
Closed -$92K 3680
2020
Q1
$92K Buy
433
+114
+36% +$36.2K ﹤0.01% 3033
2019
Q4
$131K Buy
+319
New +$110K ﹤0.01% 2787
2019
Q2
Sell
-417
Closed -$415K 3071
2019
Q1
$415K Buy
417
+20
+5% +$18.6K ﹤0.01% 1987
2018
Q4
$345K Buy
397
+292
+278% +$271K ﹤0.01% 2085
2018
Q3
$108K Buy
+105
New +$103K ﹤0.01% 2843
2018
Q2
Sell
-110
Closed -$107K 3319
2018
Q1
$107K Buy
+110
New +$100K ﹤0.01% 2910
2017
Q4
Sell
-342
Closed -$142K 3184
2017
Q3
$142K Buy
+342
New +$129K ﹤0.01% 2900
2017
Q2
Sell
-205
Closed -$105K 3172
2017
Q1
$105K Sell
205
-232
-53% -$96K ﹤0.01% 2958
2016
Q4
$155K Buy
+437
New +$185K ﹤0.01% 2548
2015
Q4
Sell
-190
Closed -$150K 2696
2015
Q3
$150K Buy
+190
New +$232K ﹤0.01% 1627

Other funds holding ATRA